UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002090
Receipt number R000002497
Scientific Title Prospective randomized controlled study of Daikenchuto for postoperative dysmotility after total gastrectomy:
Date of disclosure of the study information 2009/06/18
Last modified on 2009/06/18 17:31:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective randomized controlled study of Daikenchuto for postoperative dysmotility after total gastrectomy:

Acronym

Daikenchuto for postoperative dysmotility

Scientific Title

Prospective randomized controlled study of Daikenchuto for postoperative dysmotility after total gastrectomy:

Scientific Title:Acronym

Daikenchuto for postoperative dysmotility

Region

Japan


Condition

Condition

Gastric cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate efficacy of Daikenchuto for patients with signs and symptoms due to postoperative dysmotility after total gastrectomy

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase III


Assessment

Primary outcomes

Improvement of postoperative symptoms and signs due to gastrointestinal dysmotility including postoperative ileus, abodominal pain, distansion

Key secondary outcomes

Safety of Daikenchuto


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is considered as a block.

Blocking

YES

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Take Daikenchuto for three months

Interventions/Control_2

Not take Daikenchuto for three months

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

1)Patients expected to be undergone total gastrectomy with Curabirity A or B for gastric cancer
2)Patients should have total gastrectomy with Roux-en Y reconstraction.
3)Age: Between 20 and 80 years old regardless of gender
4)Written informed consent

Key exclusion criteria

1)Patients under emergent operation
Patients with double cancer
2)Patients with severe or uncontrollable diseases related with heart, lung, liver, and kidney
3)Patients with previous open laparotomy (except the Appendectomy)
4)Patients with pregnancy or under lactation, patients expected to be under pregnancy, and patients wish to be pregnancy
5)Patients judged inappropriate by his or her doctor

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Toshirou Nishida

Organization

Osaka University Graduate School of Medicine

Division name

Department of Gastrointestinal Surgery

Zip code


Address

2-2 Yamada-oka, Suita, Osaka

TEL

06-6879-3251

Email



Public contact

Name of contact person

1st name
Middle name
Last name Toshirou Nishida

Organization

Osaka University Graduate School of Medicine

Division name

Department of Gastrointestinal Surgery

Zip code


Address

2-2 Yamada-oka, Suita, Osaka

TEL

06-6879-3251

Homepage URL


Email



Sponsor or person

Institute

Osaka University Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Osaka Police Hospital, Osaka Koseinenkin Hospital, Osaka Rosai Hospital, Otemae Hospital, Izumisano Municipal Hospital, Osaka General Medical Center, Kobe Ekisaikai Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 06 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Date of protocol fixation

2007 Year 08 Month 04 Day

Date of IRB


Anticipated trial start date

2007 Year 09 Month 01 Day

Last follow-up date

2009 Year 11 Month 01 Day

Date of closure to data entry

2009 Year 11 Month 01 Day

Date trial data considered complete

2009 Year 11 Month 01 Day

Date analysis concluded

2010 Year 02 Month 01 Day


Other

Other related information



Management information

Registered date

2009 Year 06 Month 18 Day

Last modified on

2009 Year 06 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002497


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name